Kanakkanthara A, Jeganathan K, Limzerwala J, Baker D, Hamada M, Nam H, et al. Cyclin A2 is an RNA binding protein that controls Mre11 mRNA translation. Science. 2016;353:1549-1552 pubmed

Belmonte Fern xe1 ndez A, Herrero Ru xed z J, Galindo Moreno M, Lim xf3 n Mort xe9 s M, Mora Santos M, S xe1 ez C, et al. Cisplatin-induced cell death increases the degradation of the MRE11-RAD50-NBS1 complex through the autophagy/lysosomal pathway. Cell Death Differ. 2022;: pubmed publisher

Na J, Newman J, Then C, Syed J, Vendrell I, Torrecilla I, et al. SPRTN protease-cleaved MRE11 decreases DNA repair and radiosensitises cancer cells. Cell Death Dis. 2021;12:165 pubmed publisher

Petsalaki E, Zachos G. An ATM-Chk2-INCENP pathway activates the abscission checkpoint. J Cell Biol. 2021;220: pubmed publisher

Dhoonmoon A, Schleicher E, Clements K, Nicolae C, Moldovan G. Genome-wide CRISPR synthetic lethality screen identifies a role for the ADP-ribosyltransferase PARP14 in DNA replication dynamics controlled by ATR. Nucleic Acids Res. 2020;48:7252-7264 pubmed publisher

Zhang Y, Cai L, Wei R, Hu H, Jin W, Zhu X. Different expression of alternative lengthening of telomere (ALT)-associated proteins/mRNAs in osteosarcoma cell lines. Oncol Lett. 2011;2:1327-1332 pubmed

Iofrida C, Melissari E, Mariotti V, Guglielmi C, Guidugli L, Caligo M, et al. Effects on human transcriptome of mutated BRCA1 BRCT domain: a microarray study. BMC Cancer. 2012;12:207 pubmed publisher

Kedar P, Stefanick D, Horton J, Wilson S. Increased PARP-1 association with DNA in alkylation damaged, PARP-inhibited mouse fibroblasts. Mol Cancer Res. 2012;10:360-8 pubmed publisher